CHI3L1 and Parkinson disease: In the current study we aimed to quantify and compare CSF levels of YKL-40 in AD patients compared to patients with other neurodegenerative disorders i.e. dementia with Lewy bodies (DLB) and Parkinson’s disease (PD).